Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis

By Zagouri Flora  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 13-22

Springer Publishing Company

Access to resources Recommend Favorite

Continued Use of Trastuzumab (Herceptin) after Progression on Prior Trastuzumab Therapy in HER-2-Positive Metastatic Breast Cancer

By Pusztai Lajos   Esteva Francisco  

Cancer Investigation, Vol. 24, Iss. 2, 2006-05 ,pp. : 187-191

Informa Healthcare

Access to resources Recommend Favorite

HER2-positive Breast Cancer Brain Metastases: Multiple Responses to Systemic Chemotherapy and Trastuzumab—a Case Report

By Church D.   Bahl A.   Jones A.   Price C.  

Journal of Neuro-Oncology, Vol. 79, Iss. 3, 2006-09 ,pp. : 289-292

Springer Publishing Company

Access to resources Recommend Favorite

Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab

By                  

International Journal of Oncology, Vol. 41, Iss. 4, 2012-01 ,pp. : 1204-1212

Spandidos Publications

Access to resources Recommend Favorite

Examination of the clinical efficacy of eribulin and trastuzumab in HER2positive recurrent breast cancer

By                

Molecular and Clinical Oncology, Vol. 4, Iss. 1, 2016-01 ,pp. : 47-50

Science Publishers

Access to resources Recommend Favorite